Testing effectiveness (Phase 2)Looking for participantsNCT06802835
What this trial is testing
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Cancinoma (NPC)Recurrent Nasopharynx CarcinomaMetastatic Nasopharyngeal Carcinoma
Sun Yat-sen University 148